Literature DB >> 6175031

Neovascular glaucoma. Current management.

P A Weber.   

Abstract

Neovascular glaucoma is one the most difficult forms of glaucoma to treat successfully. Recent advances modifying filtration surgery can result in up to 77% success. Utilization of anterior and posterior segment photocoagulation can maintain an open angle in up to 80% of eyes when they are treated prior to angle closure by peripheral anterior synechiae. Destruction of the ciliary body can be performed more selectively utilizing argon and ruby lasers. This paper presents a rational approach to the management of neovascular glaucoma incorporating these recent advances.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6175031     DOI: 10.1016/0039-6257(81)90063-1

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

1.  Panretinal cryotherapy in neovascular disease.

Authors:  S A Vernon; H Cheng
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

2.  The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).

Authors:  Peter A Netland
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

3.  Surgical results of pars plana vitrectomy combined with pars plana lensectomy with anterior capsule preservation, endophotocoagulation, and silicon oil tamponade for neovascular glaucoma.

Authors:  Nozomi Kinoshita; Ayumi Ota; Fumihiko Toyoda; Hiroko Yamagami; Akihiro Kakehashi
Journal:  Clin Ophthalmol       Date:  2011-12-16

4.  Outcomes of Ahmed glaucoma valve and transscleral cyclophotocoagulation in neovascular glaucoma.

Authors:  Wesam S Shalaby; Allen Y Ganjei; Brian Wogu; Jonathan S Myers; Marlene R Moster; Reza Razeghinejad; Daniel Lee; Natasha N Kolomeyer; Tarek E Eid; L Jay Katz; Aakriti G Shukla
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

5.  Management of intraocular pressure elevation during hemodialysis of neovascular glaucoma: a case report.

Authors:  P Frezzotti; C Menicacci; S A Bagaglia; P Mittica; F Toto; I Motolese
Journal:  BMC Ophthalmol       Date:  2016-03-05       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.